Enzymatica AB (ENZY) Stock Statistics & Valuation Metrics

Enzymatica AB has a market cap or net worth of kr446.63M. The enterprise value is kr538.65M.

Enzymatica AB has 242,735,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Enzymatica AB’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -29.06%.

The current PE Ratio of Enzymatica AB is ―. Enzymatica AB’s PEG ratio is 0.00.

In the last 12 months, Enzymatica AB had revenue of 45.58M and earned -53.18M in profits. Earnings per share was -0.28.

In the last 12 months, operating cash flow was -61.99M and capital expenditures 11.34M, giving a free cash flow of -50.66M billion.

Enzymatica AB pays an annual dividend of ―, resulting in a dividend yield of ―

Enzymatica AB upcoming earnings date is Feb 18, 2026, Before Open (Confirmed).

Enzymatica AB as a current ratio of 6.28, with Debt / Equity ratio of 1.11%

In the past 12 months, Enzymatica AB has paid -159.00K in taxes.

Enzymatica AB EV to EBITDA ratio is -4.70, with an EV/FCF ratio of -3.80.

Enzymatica AB has kr33.08M in cash and marketable securities with kr1.30M in debt, giving a net cash position of kr31.77M billion.

Gross margin is 66.13%, with operating margin of -114.22%, and net profit margin of -116.68%.

The average price target for Enzymatica AB is ―, which is 11.43% higher than the current price. The consensus rating is ―